von Willebrand factor (VWF) is a key component of the blood coagulation system. Deficiencies of VWF result in the most common inherited bleeding disorder in humans, von Willebrand disease (VWD). In contrast, elevated levels of VWF and the associated protein, factor VIII, are a major risk factor for thrombosis. This is an application for competing renewal of a research program focused on the molecular genetics of VWF. Considerable progress was made over the last funding cycle, including the identification of multiple genetic factors regulating the plasma level of VWF in laboratory mice and in humans. In addition, the genes for 2 related disorders of VWF and FVIII were identified: ADAMTS13 as the cause of familial thrombotic thrombocytopenic purpura (TTP) and MCFD2/LMAN1 as the cause of combined deficiency for factors V and VIII. The current proposal will continue and extend the body of work from the previous funding cycle. The 8 genetic loci that were previously identified to contribute to variability in plasma VWF levels among inbred mouse strains (Mvwf1-8) will be further characterized at the molecular level. Building on initial preliminary studies, direct genetic analysis for human modifiers of VWF and other hemostatic factors will be conducted using a cohort of 1182 healthy young subjects collected at the University of Michigan. In addition, a new approach will be undertaken to extend this genetic strategy to identify potential genetic modifiers of VWF levels in a zebrafish model system. The genetic power of the mouse and zebrafish systems may facilitate the identification of the critical genes modifying plasma VWF levels in humans, as well as yielding information about fundamental VWF biology that could lay the ground work for novel approaches to diagnosis and treatment in the future. Finally, the application of new high throughput sequencing technologies to a modified phage display strategy will be used to finely map functional domains within the VWF protein and to select for novel recombinant proteins with potential therapeutic utility.

Public Health Relevance

The studies proposed in this application will advance understanding of the molecular and genetic basis for decreased von Willebrand factor levels that result in bleeding in von Willebrand disease and elevated VWF levels associated with many cases of abnormal blood clotting (thrombosis). These findings should lead to improved diagnosis for both inherited bleeding and blood clotting diseases and facilitate more tailored selection of therapy in individual patients. These studies may also lay the groundwork for the development of new therapies in the future to treat both common bleeding and blood clotting diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039693-24
Application #
8625805
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Link, Rebecca P
Project Start
1988-12-01
Project End
2016-02-29
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
24
Fiscal Year
2014
Total Cost
$755,439
Indirect Cost
$226,303
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Adams, Elizabeth J; Chen, Xiao-Wei; O'Shea, K Sue et al. (2014) Mammalian COPII coat component SEC24C is required for embryonic development in mice. J Biol Chem 289:20858-70
Ozel, A Bilge; Moroi, Sayoko E; Reed, David M et al. (2014) Genome-wide association study and meta-analysis of intraocular pressure. Hum Genet 133:41-57
Everett, Lesley A; Cleuren, Audrey C A; Khoriaty, Rami N et al. (2014) Murine coagulation factor VIII is synthesized in endothelial cells. Blood 123:3697-705
Yee, Andrew; Gildersleeve, Robert D; Gu, Shufang et al. (2014) A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice. Blood 124:445-52
Khoriaty, Rami; Vasievich, Matthew P; Jones, Morgan et al. (2014) Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B. Mol Cell Biol 34:3721-34
Yee, Andrew; Tan, Fen-Lai; Ginsburg, David (2013) Functional display of platelet-binding VWF fragments on filamentous bacteriophage. PLoS One 8:e73518
Desch, Karl C; Ozel, Ayse B; Siemieniak, David et al. (2013) Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association. Proc Natl Acad Sci U S A 110:588-93
Baines, Andrea C; Adams, Elizabeth J; Zhang, Bin et al. (2013) Disruption of the Sec24d gene results in early embryonic lethality in the mouse. PLoS One 8:e61114
Zhang, Bin; Zheng, Chunlei; Zhu, Min et al. (2011) Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of ýý1-antitrypsin. Blood 118:3384-91
Ginsburg, David (2011) Genetics and genomics to the clinic: a long road ahead. Cell 147:17-9

Showing the most recent 10 out of 40 publications